Navigation Links
Researchers at the University of Granada associate trigger points with shoulder injury
Date:9/30/2010

This release is available in Spanish.

Researchers of the University of Granada, in collaboration with the Centre for Sensory-Motor Interaction of the University of Aalborg, Denmark, and the University Rey Juan Carlos, Madrid, conducted a research on chronic impingement syndrome. The study revealed that excessive activation of specific neck and shoulder muscles during daily life or while playing sports as swimming is the cause of a high number of injury and shoulder

A Common Pain

The pattern of the pain originated in these muscles sometimes in regions far from the shoulder coincides with most of the symptoms suffered by patients attending health care centers for this type of problem. 25 out of 1,000 visits to the family doctor are related to shoulder pain, and the causes of this problem are several. The chronic impingement syndrome is considered the main cause for shoulder pain and disability.

The study conducted by Amparo Hidalgo-Lozano, Ph.D candidate of the department of Physiotherapy of the University of Granada, under the supervision of professor Manuel Arroyo Morales, opens the door to future tests to the efficacy of Physiotherapy as a non-invasive treatment for shoulder injury. Shoulder injury is the cause of 13% of sick leaves and implies a cost of 7 billion dollars in the USA.

This research was published in the last issue of the prestigious journal Experimental Brain Research.


'/>"/>

Contact: Manuel Arroyo Morales
marroyo@ugr.es
34-620-936-138
University of Granada
Source:Eurekalert  

Page: 1

Related medicine news :

1. Researchers to study effects of Mass. health reform
2. IU researchers: Chemotherapy alters brain tissue in breast cancer patients
3. Researchers use CT to predict heart disease
4. VCU study: Researchers discover a drug combination that shrinks tumors in vivo
5. Sugary sports drinks mistakenly associated with being healthy, say UTHealth researchers
6. Researchers create first molecule blocks key component of cancer genes on-off switch
7. Researchers create first molecule-blocks key component of cancer genes on-off switch
8. Team of researchers finds possible new genetic risk for Alzheimers disease
9. UCLA cancer researchers discover new signaling pathway that controls cell development and cancer
10. European Researchers Find Genes Tied to Asthma
11. New treatment for severe aortic stenosis shown to save lives, Stanford researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at the University of Granada associate trigger points with shoulder injury
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... , , , ... In an unprecedented and historic show of unity, advocates for all ... countries with reneging on their commitments to health by chronically underfunding programs ... health systems strengthening across the globe. , , ...
... ... Z-Folded design with antibacterial effectiveness. , ... Portland, OR (Vocus) July 21, 2009 -- HemCon Medical Technologies, ... is a next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care ...
... , , , ... Board: PTSH) today announced that its subsidiary, Disability Access Corporation ... Inc. (DAC) has signed a $245,000 contract with Tuolumne Joint ... renewed its contract (not to exceed $120,000) with the Office ...
... , , , ... DGX ), the world,s leading provider of diagnostic testing, information and ... income from continuing operations rose to $188 million, or $1.00 per ... the second quarter of 2008. These results include a previously disclosed ...
... , , , , ... the popular nutritional juice cleanse Food & ... groundswell of requests from the Golden State by announcing today that it will ... September 7. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090721/LA49137 ...
... ... ... 2009 -- A recent study has found that post-menopausal women who underwent synthetic hormone ... 900,000 Danish women between the ages of 50 to 79 and resulted with scientists ...
Cached Medicine News:Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 2Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 4Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 5Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 6Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 7Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 8Health News:Next-Generation Hemostatic Dressing Available for Military Emergencies 2Health News:Next-Generation Hemostatic Dressing Available for Military Emergencies 3Health News:PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 3Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 5Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 6Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 7Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 8Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 9Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 10Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 11Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 12Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 13Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 14Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 2Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 3Health News:New Study Finds Yet Another Link to Cancer, Synthetic Hormones 2
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... , May 12 Carrot Medical, a ... MAVIG GmbH, the leading manufacturer of medical imaging monitor ... marketing and sales channel partnership agreement. This partnership provides ... through MAVIG,s global sales channel while offering MAVIG access ...
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Antifungal Drugs: Technologies and Global Markets , ... , , , ... , An examination of the major ...
Cached Medicine Technology:Carrot Medical Partners with MAVIG GmbH 2Carrot Medical Partners with MAVIG GmbH 3Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 2Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 3Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 4Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 5Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 6Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 7Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 8Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 9Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 10Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 11Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 12Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 13Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 14
Ethicon, medium clip size, 10mm, rotatable take apart...
Solid phase capture sandwich ELISA assay using a microwell format....
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI...
... first compact, broad menu clinical chemistry analyzer ... treatment setting. Care givers can now perform ... than one minute of hands-on time. Complete ... to larger, expensive laboratory analyzers are available ...
Medicine Products: